University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Effects of Varenicline in Heavy Drinking Smokers

Phase 4

Withdrawn

Conditions: Cigarette Smoking
Alcohol Consumption

Interventions: Drug: Varenicline
Drug: Alcohol
Drug: Placebo pill (for varenicline)
Drug: placebo beverage (for alcohol)

First Posted Date: 2015-07-02

Last Posted Date: 2018-06-01

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT02488889

Locations: 🇺🇸
UCLA Addictions Laboratory, Los Angeles, California, United States

Writing About Experiences and Health in Older Adults

Not Applicable

Completed

Conditions: Social Psychology

First Posted Date: 2015-06-15

Last Posted Date: 2017-05-02

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 78

Registration Number: NCT02472379

Locations: 🇺🇸
UCLA Clinical & Translational Research Center (CTRC), Los Angeles, California, United States

Trial of Levomilnacipran in Geriatric Depression

Phase 4

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: Placebo
Drug: levomilnacipran

First Posted Date: 2015-06-09

Last Posted Date: 2019-08-14

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 29

Registration Number: NCT02466958

Locations: 🇺🇸
UCLA Semel Institute - Neuropsychiatric Institute (NPI), Los Angeles, California, United States

Brain Connectivity and Response to Tai Chi in Geriatric Depression

Not Applicable

Completed

Conditions: Major Depressive Disorder

Interventions: Behavioral: Health Education and Wellness Classes (HEW)
Behavioral: Tai-Chi-Chih (TCC)

First Posted Date: 2015-06-02

Last Posted Date: 2021-07-16

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 220

Registration Number: NCT02460666

Locations: 🇺🇸
UCLA Semel Institute, Los Angeles, California, United States

The Cirrhosis Outpatient Optimization, Readmission & Safety Study

Early Phase 1

Terminated

Conditions: Cirrhosis

Interventions: Device: Vivify Kit

First Posted Date: 2015-05-29

Last Posted Date: 2017-10-26

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 120

Registration Number: NCT02457988

Locations: 🇺🇸
UCLA Center for Inflammatory Bowel Diseases, Los Angeles, California, United States

Abatacept for SLE Arthritis (IM101-330)

Phase 1

Terminated

Conditions: Systemic Lupus Erythematosus Arthritis

Interventions: Biological: abatacept also known as Orencia also known as CTLA4-Ig
Drug: Placebo

First Posted Date: 2015-04-29

Last Posted Date: 2021-05-13

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 28

Registration Number: NCT02429934

Locations: 🇺🇸
University of California, San Diego, San Diego, California, United States
🇺🇸
UCLA David Geffen School of Medicine, Division of Rheumatology, Los Angeles, California, United States

FORE-SIGHT Tissue Oximeter During Cardiac Surgery

Completed

Conditions: Cardiac Surgical Patients

First Posted Date: 2015-04-24

Last Posted Date: 2020-11-03

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 55

Registration Number: NCT02426268

Locations: 🇺🇸
Ronald Reagan UCLA Medical Center, Department of Anesthesiology, Los Angeles, California, United States

Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas

Not Applicable

Completed

Conditions: Developmental, Behavioral and Mental Health
Adhd
Developmental Delay
Depression
Behavioral Problems
Autism
Anxiety

Interventions: Behavioral: Telehealth Intervention

First Posted Date: 2015-03-24

Last Posted Date: 2017-08-10

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 359

Registration Number: NCT02396576

Locations: 🇺🇸
Northeast Valley Health Corporation- Canoga Park, Canoga Park, California, United States
🇺🇸
Northeast Valley Health Corporation- San Fernando, San Fernando, California, United States
🇺🇸
Northeast Valley Health Corporation- Santa Clarita, Santa Clarita, California, United States

and more 3 locations

Vasopressin and the Social Brain

Early Phase 1

Completed

Conditions: Social Psychology

Interventions: Drug: Intranasal vasopressin
Drug: Intranasal placebo

First Posted Date: 2015-03-20

Last Posted Date: 2017-08-10

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 84

Registration Number: NCT02394054

Locations: 🇺🇸
UCLA Department of Psychology, Los Angeles, California, United States

Oxytocin and Learning for Teaching

Early Phase 1

Completed

Conditions: Social Psychology

Interventions: Drug: Intranasal oxytocin
Drug: Intranasal placebo

First Posted Date: 2015-03-19

Last Posted Date: 2017-08-10

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 161

Registration Number: NCT02393443

Locations: 🇺🇸
UCLA Department of Psychology, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy